Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 236

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Expert consensus document from the European Society of Cardiology on catheter-based renal denervation

Open access
Mahfoud, Felix, Lüscher, Thomas Felix, Andersson, Bert, Baumgartner, Iris, Cifkova, Renata, DiMario, Carlo, Doevendans, Pieter, Fagard, Robert, Fajadet, Jean, Komajda, Michel, LeFèvre, Thierry, Lotan, Chaim, Sievert, Horst, Volpe, Massimo, Widimsky, Petr, Wijns, William, Williams, Bryan, Windecker, Stephan, Witkowski, Adam, Zeller, Thomas, Böhm, Michael · 2013 · European Heart Journal

Abstract

Hypertension is highly prevalent and one of the most frequent chronic diseases worldwide.1 It has been suggested that over the next two decades up to 50% of the adult population will be diagnosed with hypertension, according to the standard guideline definitions.1 Despite the availability of many safe and effective antihypertensive drugs, control rates to target blood pressure remain low.2 Approximately 5–10% of all patients with high blood pressure are resistant to drug treatment defined as blood pressure >140/90 mmHg, >130–139/80–85 mmHg in diabetes mellitus or >130/80 mmHg in chronic kidney disease in the presence of three or more antihypertensives of different classes, including a diuretic, at maximal or the highest tolerated dose.3 Resistant hypertension is associated with an increased risk of cardiovascular events.4 Current non-invasive therapeutic strategies are mainly based on lifestyle interventions and pharmacological treatment, including mineralocorticoid receptor antagonists.3 Up until recently treatment options for patients with resistant hypertension were limited. Nowadays catheter-based renal denervation offers a new approach targeting the renal sympathetic nerves. Indeed, the technique has been shown to reduce sympathetic nerve activity,5 norepinephrine spillover6 as well as blood pressure7–9 in patients with resistant hypertension. Several national10–13 and international14 consensus documents from different societies have recently been published, with different degrees of involvement of interventionalists. This expert consensus document summarizes the view of an expert panel of the European Society of Cardiology and the European Association of Percutaneous Cardiovascular Interventions to provide guidance regarding appropriate patient selection, efficacy, safety, limitations, and potential new indications of renal denervation for referring physicians, interventionalists, and healthcare providers. The aetiology of resistant hypertension is multi-factorial. However, there is a large body of evidence indicating the crucial role of the sympathetic nervous system in most types of hypertension and numerous cardiovascular diseases, including heart failure, chronic kidney disease, and the metabolic syndrome.15,16 Afferent and efferent sensory, chemo- and baroreceptor nerve fibres, form a neural network within the adventitia of the renal artery (Figure 1).17 Renal afferent nerves connect the kidney with the hypothalamus, and are activated by renal ischaemia and high local adenosine concentrations.18 Renal afferent nerve traffic contributes to central sympathetic activity generated in the solitary tract and nucleus. Efferent nerves innervate the renal vasculature, the tubular segment of the nephron, and juxtaglomerular renin-containing granular cells, enhancing sodium and water retention, stimulating renin release, and altering renal blood flow.16 These effects influence both short- and long-term blood pressure regulation. Their convenient location in the renal artery adventitia means that both the efferent and afferent fibres can now be targeted by catheter-based approaches, thereby re-setting renal blood pressure regulation. Catheter-based radiofrequency ablation has been shown to be as effective as surgical denervation in terms of reducing kidney norepinephrine content in pigs (Figure 2).19 Efferent and afferent renal sympathetic nerves (modified with permission from Lüscher, PCR-EAPCI Textbook). HR, heart rate; RBF, renal blood flow; GFR, glomerular filtration rate. Tissue norepinephrine content in untreated controls and pigs undergoing catheter-based renal denervation and surgical denervation (modified from19). Numerous new percutaneous renal nerve ablation systems are currently being tested and will soon be released into the market. Up to now, five Conformité Européenne-marked renal denervation systems using different treatment strategies are available: Medtronic's Symplicity system, St. Jude's EnligHTN system, Vessix's V2 system, Covidien's One Shot system, and Recor's Paradise system (for details, see Table 1). Most of these systems use radiofrequency energy to target renal sympathetic nerves except for the ultrasound-based Recor's Paradise system. The devices are all inserted percutaneously via a femoral access and advanced under fluoroscopic control. Beforehand, however, renal artery anatomical suitability for the procedure should be established, i.e. a renal artery length is ideally >20 mm with a diameter of >4 mm. When considering renal nerve ablation, arteries with visible stenosis, with calcification or atheromatous plaques, represent relative contraindications. Anectodical reports of renal denervation in arteries with significant stenosis (>50%) or previous revascularization have been reported, but this off-label use should be avoided. Recently published data indicated that the applied radiofrequency energy resulted in transient local de-endothelialization, acute cellular swelling, conn

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/eht154

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 236

Metadata

Authors
Mahfoud, F., Lüscher, T. F., Andersson, B., Baumgartner, I., Cifkova, R., DiMario, C., Doevendans, P., Fagard, R., Fajadet, J., Komajda, M., LeFèvre, T., Lotan, C., Sievert, H., Volpe, M., Widimsky, P., Wijns, W., Williams, B., Windecker, S., Witkowski, A., Zeller, T., & Böhm, M.
Venue
European Heart Journal
Published
2013-04-25
Volume
34
Issue
28
Pages
2149-2157
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2135447024
Cited by
236
References
12
FWCI
39.19
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. https://app.cochat.ai/papers/10.1093/eurheartj/eht154
The paper
Mahfoud, F., Lüscher, T. F., Andersson, B., Baumgartner, I., Cifkova, R., DiMario, C., Doevendans, P., Fagard, R., Fajadet, J., Komajda, M., LeFèvre, T., Lotan, C., Sievert, H., Volpe, M., Widimsky, P., Wijns, W., Williams, B., Windecker, S., Witkowski, A., . . . Böhm, M. (2013). Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. European Heart Journal. https://doi.org/10.1093/eurheartj/eht154

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.